The FDA has outlined numerous concerns about the sale and use of unapproved GLP-1 drugs for weight loss.  “FDA is aware that ...

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

Vunakizumab, an interleukin-17 inhibitor, shows improved efficacy over placebo in treating active psoriatic arthritis at week 12, with mild or moderate treatment-emergent adverse events.

In the first large randomized trial to prospectively assess cognition, carotid revascularization shows no cognitive advantage over intensive medical therapy alone.